2026 NPPES data Dermatology Physician NPI 1306289574 M.D.
Verify on CMS →

NICHOLAS BONTUMASI, M.D.

Dermatology Physician in GRAND HAVEN, Michigan. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
1K
Medicare Part D claims · 510 beneficiaries · Dermatology Physician avg: 729
Generic prescribing
95%
generic claims · 5% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
93.2552/100
▲ 10 pts above national avg 83.1 · [object Object]
Industry payments
$767.11
43 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

NICHOLAS BONTUMASI, M.D. reported a CMS MIPS final score of 93.2552/100 — above the 83.1 national average — and filed 1,088 Medicare Part D claims in 2023.

93.2552/100
MIPS score · +10 vs avg
1K
Part D claims, 2023
95%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

NICHOLAS BONTUMASI, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

93 Top 29% higher than 71% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

NICHOLAS BONTUMASI, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about NICHOLAS BONTUMASI, M.D.?

High performer (top quartile)

NPI registry status

Active

Issued 04/08/2013

NPI 1306289574

Primary specialty

Dermatology Physician

Mid-sized

14,610 US NPIs in this specialty

Medicare Part D claims

1,088 49% vs specialty avg

2023 prescription claims

Specialty avg: 729

MIPS final score

93.2552/100 10.155200000000008% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Michigan

How Dermatology Physician compares to other specialties among Michigan providers

Michigan providers

Dermatology Physician share within Michigan

1. Dermatology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Dermatology Physician share within Michigan

Medicare quality performance — MIPS

NICHOLAS BONTUMASI, M.D.'s 2023 MIPS final score plotted against the Dermatology Physician national average

High performer (top quartile)
MIPS Final Score
93.2552/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Dermatology Physician) — 93.2552/100 vs national avg 83.1

0%100%National avg83%93.3%
MIPS final score (Dermatology Physician) — 93.2552/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

NICHOLAS BONTUMASI, M.D. appears in the CMS NPPES registry as a Dermatology Physician provider holding M.D. credentials at 1600 S BEACON BLVD STE 160, GRAND HAVEN, MI, 49417, with a listed phone of (616) 268-2001. NPI 1306289574 was issued on 04/08/2013. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BONTUMASI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,088 prescription claims written by this provider, covering 510 Medicare beneficiaries and totaling roughly $287K in drug spend, split 5% brand-name and 95% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 93.2552/100 for the 2023 performance year (Quality 87.7367), compared with the national average of 83.1.

Dermatology Physician is a mid-sized specialty nationwide, with 14,610 enrolled providers across 53 states and an average of 729 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1600 S BEACON BLVD STE 160
GRAND HAVEN, MI 49417

Provider Details

NPI 1306289574
Specialty Dermatology Physician
Credentials M.D.
Gender Male
NPI Issued 04/08/2013

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

93.2552
Final Score
Avg: 83.1
87.7367
Quality
100
Promoting Interoperability

Reporting: Individual

Hospital and facility affiliations

Facilities where NICHOLAS BONTUMASI, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

FOREFRONT DERMATOLOGY SC
MARQUETTE, MI

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for NICHOLAS BONTUMASI, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$767

Largest payer

Regeneron Healthcare Solutions, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Michigan MI-BOM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~41K Michigan medical licensees in 2023 — they are NOT specific to NICHOLAS BONTUMASI, M.D.. To verify NICHOLAS BONTUMASI, M.D.'s current license status, search the MI-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

123
Total board actions, Michigan 2023
Across 120 cases
3.00
Actions per 1,000 licensees
Michigan statewide rate
probation
Most common action type
44 cases

MI-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Michigan disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

NICHOLAS BONTUMASI, M.D. — brand share 5.0%
Specialty average (est.)

5% brand-name claims vs 95% generic, on 1,088 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,088
Total Claims
$287K
Total Drug Cost
510
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,264
Total Day Supply
31,989
Brand vs Generic
5% brand / 95% generic
Brand Drug Cost
$234K
Generic Drug Cost
$53K
Antibiotic Claims
61

Patient Demographics

Average Patient Age
73.9 years
Avg HCC Risk Score
1.00
Gender Split
48% female / 52% male
Age Distribution
<65: 24, 65-74: 254, 75-84: 188, 85+: 44

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What NICHOLAS BONTUMASI, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Fluorouracil
175
Triamcinolone Acetonide
170
Clobetasol Propionate
147
Ketoconazole
146
Betamethasone Dipropionate
72
Doxycycline Hyclate
54
Mupirocin
54
Metronidazole
47
Tacrolimus
25
Hydrocortisone
24

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Dermatology Physician Overview

How NICHOLAS BONTUMASI, M.D. fits within the Dermatology Physician landscape nationally.

14,610
Dermatology Physician Providers in US
53
States with Dermatology Physician
729
Avg Claims per Provider

NICHOLAS BONTUMASI, M.D.'s 1,088 claims are above the specialty average of 729.

Nearby Dermatology Physician Providers in Michigan

Other clinicians with the same primary specialty enrolled in Michigan, drawn from the same CMS NPPES roster as BONTUMASI.

Compare Dermatology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is NICHOLAS BONTUMASI, M.D.'s specialty?
NICHOLAS BONTUMASI, M.D. specializes in Dermatology Physician and practices in GRAND HAVEN, Michigan. Credentials: M.D..
How much does NICHOLAS BONTUMASI, M.D. prescribe under Medicare Part D?
In 2023, NICHOLAS BONTUMASI, M.D. wrote 1,088 Medicare Part D claims totaling $287K in drug costs for 510 beneficiaries.
What is NICHOLAS BONTUMASI, M.D.'s Medicare quality score?
NICHOLAS BONTUMASI, M.D. has a CMS MIPS Final Score of 93.2552/100 (Quality: 87.7367). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is NICHOLAS BONTUMASI, M.D. located?
NICHOLAS BONTUMASI, M.D. is located at 1600 S BEACON BLVD STE 160, GRAND HAVEN, MI, 49417. Phone: (616) 268-2001.
What is NICHOLAS BONTUMASI, M.D.'s NPI number?
NICHOLAS BONTUMASI, M.D.'s National Provider Identifier (NPI) is 1306289574, issued on 04/08/2013.
Does NICHOLAS BONTUMASI, M.D. prescribe more brand-name or generic drugs?
NICHOLAS BONTUMASI, M.D.'s prescribing is 5% brand-name and 95% generic drugs by claim count, with $234K in brand drug costs.
How many Dermatology Physician providers are there in the US?
There are 14,610 Dermatology Physician providers across 53 states in the US. The average Dermatology Physician provider writes 729 Medicare Part D claims per year.
What drugs does NICHOLAS BONTUMASI, M.D. prescribe most often?
Based on 2023 Medicare Part D data, NICHOLAS BONTUMASI, M.D.'s most frequently prescribed drugs include Fluorouracil, Triamcinolone Acetonide, Clobetasol Propionate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does NICHOLAS BONTUMASI, M.D. accept Medicare?
NICHOLAS BONTUMASI, M.D. appears in CMS Medicare data with 1,088 Part D claims and 510 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify NICHOLAS BONTUMASI, M.D.'s credentials?
NICHOLAS BONTUMASI, M.D.'s NPI is 1306289574 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology